Clinical Trial Update: A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2 study evaluating serabelisib in combination with canagliflozin in advanced solid tumors; current status unclear.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer

Drugs mentioned

• Canagliflozin (canagliflozin)
• Serabelisib (serabelisib)

Snippet

Sponsor: Petra Pharma | Conditions: Breast Cancer, Endometrial Cancer | Phase 1, Phase 2 | Status: UNKNOWN